Featured Article
The large-scale, randomized, controlled study of 5,018 women showed that targeted interventions based on the Sera PreTRM test results significantly improve newborn health and decrease NICU admissions and length of stay.
Precision Oncology Today
Magazine
The Importance of Increasing Diversity in Clinical Trials
Before reaching the market, new drugs are tested in people who voluntarily participate in clinical trials. However, for a new medicine to work in as many people as possible, these drugs should be tested in a patient population that is as diverse as possible.
When It Comes to Space Precision Medicine, the Sky Is the Limit—Literally
Based on a growing body of data, some experts believe that pharmacogenomics-guided spaceflight is the foundation of precision medicine, a feature that they believe will enable long-term human habitation on the Moon.
Trending on Inside Precision Medicine
Gene-Edited Pig Kidney Successfully Xenotransplanted in Living Patient at MGH
There is huge momentum in the field of kidney xenotransplantation, as the FDA approves clinical trials for the first time and Massachusetts General Hospital performs the fourth operation on record.
Stroke Medication Treatment Window Could Be Wider
Research shows the stroke drug alteplase could be used up to 24 hours after the initial event occurs and still be beneficial for patients.
Body Dimension and Cholesterol Changes Apparent Years before Dementia Diagnosis
Cardiometabolic changes could take place a decade before the diagnosis of dementia, research suggests, providing a window of opportunity for its prevention.
Daily News
Podcast Series
Behind the Breakthroughs
Join host Jonathan D. Grinstein, PhD, North American Editor for Inside Precision Medicine, as he uncovers the stories behind the pioneers driving the precision medicine revolution.
Stay up to date with the latest episodes of Behind the Breakthroughs by subscribing to the IPM eNewsletter.
